Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Chemotherapy and Autologous Stem Cell Rescue for Primary Amyloidosis

NCT00186407 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00186407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00186407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Chemotherapy and Autologous Stem Cell Rescue for Primary Amyloidosis
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 1998
Completion date
February 28, 2010
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, blood and marrow transplant (bmt)